{
 "as_of": "2026-11-06",
 "cmr": "fr-cm-kg/XPAR/FR0013183985",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# GENSIGHT BIOLOGICS (Euronext Paris: FR0013183985) — research page\n\nAs of 2026-11-06 · fr-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is GENSIGHT BIOLOGICS, listed on Euronext Paris under ticker FR0013183985, with ISIN FR0013183985 and LEI 549300NK4AB8OUEX1F54. Its security type is Corporate, its segment is not on the record, its sector is NAF 72.19Z, and its jurisdiction is France (RCS-registered SA à conseil d'administration (s.a.i.)). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 25 filings in the twelve months to 2026-11-06, across 20 filing days. The median gap between filing days is 14 days. The latest filing is dated 2026-10-16, 21 days before the record date, and is a newswire release. The exchange median is 8.0 days of cadence gap, 15.0 filings and 3 days of latency across 316 issuers. The sector median is 8.0 days of cadence gap, 17 filings and 7 days of latency across 17 issuers.\n\n## Auditor\n\nThe auditor is not on the record. The width records only the annual report link, which is a source link and not a read. The auditor's location and any auditor changes are not on the record.\n\n## Events and halts\n\nThe record does not carry listing, delisting, name change, domicile change or segment move events, because no lifecycle type map exists for this register yet. The issuer is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/fr/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThree research houses are named on the issuer's own investor-relations page: Daniil Gataulin (US), Martial Descoutures (FR) and Justine Telliez (FR).\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (identity.exchange)\n- https://recherche-entreprises.api.gouv.fr/search?q=751164757 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.fr-cm-kg.ai/events/XPAR/FR0013183985 (the disclosure lines)\n- https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current (the halt flag)\n- https://mcp.fr-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.gensight-biologics.com/investors/ (coverage)\n- https://mcp.fr-cm-kg.ai/record/XPAR/FR0013183985 (the record)\n",
 "market": "FR",
 "node": "fr-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the FR vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "FR",
    "reason": "Width 0 records the annual report link only (ORDER-016: source link, not a read)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "FR",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "FR",
    "state": "not_on_record"
   },
   "changes": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "fr-cm-kg/XPAR/FR0013183985",
  "coverage": {
   "count": 3,
   "houses": [
    {
     "house": "Daniil Gataulin (US)",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gensight-biologics.com/investors/",
     "state": "sourced"
    },
    {
     "house": "Martial Descoutures (FR)",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gensight-biologics.com/investors/",
     "state": "sourced"
    },
    {
     "house": "Justine Telliez (FR)",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gensight-biologics.com/investors/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.gensight-biologics.com/investors/",
     "result": "read: 3 of 6 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 316,
     "median_cadence_gap_days": 8,
     "median_filings": 15,
     "median_latency_days": 3,
     "name": "Euronext Paris"
    },
    "sector": {
     "issuers": 17,
     "median_cadence_gap_days": 8,
     "median_filings": 17,
     "median_latency_days": 7,
     "name": "NAF 72.19Z"
    }
   },
   "by_type": {
    "agm_egm": 1,
    "newswire_release": 17,
    "prospectus": 1,
    "regulatory_filing": 6
   },
   "cadence_median_gap_days": 14,
   "filing_days": 20,
   "filings": 25,
   "latency_days": 21,
   "latest": [
    {
     "category": null,
     "date": "2026-10-16",
     "source": "https://www.businesswire.com/news/home/20261016616410/en/GenSight-Biologics-Announces-the-Closing-of-its-%E2%82%AC1.0-Million-Fundraising-Supported-by-Existing-Shareholders",
     "title": "GenSight Biologics Announces the Closing of its €1.0 ...",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-08",
     "source": "https://www.businesswire.com/news/home/20261007822305/en/GenSight-Biologics-Announces-a-Successful-%E2%82%AC1.0-Million-Fundraising-Supported-by-Existing-Shareholders",
     "title": "GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-08",
     "source": "https://www.businesswire.com/news/home/20261007442702/en/GenSight-Biologics-Reports-Cash-Position-as-of-September-30-2026",
     "title": "GenSight Biologics Reports Cash Position as of September ...",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-08",
     "source": "https://www.businesswire.com/news/home/20261007247351/en/Gensight-Biologics-and-the-15-20-National-Hospital-Announce-NEJM-Publication-on-GS030-Phase-12-Trial-Results-in-Late-Stage-Retinitis-Pigmentosa",
     "title": "Gensight Biologics and the 15-20 National Hospital ...",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-09-08",
     "source": "https://www.businesswire.com/news/home/20260907527861/en/GenSight-Biologics-Provides-September-2026-Business-Updates",
     "title": "GenSight Biologics Provides September 2026 Business Updates",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2026-10-16",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.fr-cm-kg.ai/events/XPAR/FR0013183985",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "Euronext Paris"
   },
   "isin": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "confirmed",
    "value": "FR0013183985"
   },
   "jurisdiction": {
    "read_by": "French State company search (recherche-entreprises.api.gouv.fr; INSEE / RNE register data) (nature juridique)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://recherche-entreprises.api.gouv.fr/search?q=751164757",
    "state": "sourced",
    "value": "France (RCS-registered SA à conseil d'administration (s.a.i.))"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN FR0013183985)",
    "state": "sourced",
    "value": "549300NK4AB8OUEX1F54"
   },
   "name": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "GENSIGHT BIOLOGICS"
   },
   "sector": {
    "read_by": "French State company search (recherche-entreprises.api.gouv.fr; INSEE / RNE register data) (activité principale, NAF)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://recherche-entreprises.api.gouv.fr/search?q=751164757",
    "state": "sourced",
    "value": "NAF 72.19Z"
   },
   "security_type": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "FR",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "FR0013183985"
   },
   "website": {
    "market": "FR",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "FR",
  "node": "fr-cm-kg",
  "numbers_hash": "sha256:cef935b13ce7041ee8d2a99204dca465a17181ffe97526812461bdfbd889a1e8",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.fr-cm-kg.ai/book/aio.json",
    "door": "https://mcp.fr-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/fr/mifid-ii-product-governance/r1",
   "section": "fr.aio.v10"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.fr-cm-kg.ai/record/XPAR/FR0013183985",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:cef935b13ce7041ee8d2a99204dca465a17181ffe97526812461bdfbd889a1e8",
 "path": "/fr/XPAR/FR0013183985",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is GENSIGHT BIOLOGICS, listed on Euronext Paris under ticker FR0013183985, with ISIN FR0013183985 and LEI 549300NK4AB8OUEX1F54. Its security type is Corporate, its segment is not on the record, its sector is NAF 72.19Z, and its jurisdiction is France (RCS-registered SA à conseil d'administration (s.a.i.)). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 25 filings in the twelve months to 2026-11-06, across 20 filing days. The median gap between filing days is 14 days. The latest filing is dated 2026-10-16, 21 days before the record date, and is a newswire release. The exchange median is 8.0 days of cadence gap, 15.0 filings and 3 days of latency across 316 issuers. The sector median is 8.0 days of cadence gap, 17 filings and 7 days of latency across 17 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record. The width records only the annual report link, which is a source link and not a read. The auditor's location and any auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record does not carry listing, delisting, name change, domicile change or segment move events, because no lifecycle type map exists for this register yet. The issuer is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/fr/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "Three research houses are named on the issuer's own investor-relations page: Daniil Gataulin (US), Martial Descoutures (FR) and Justine Telliez (FR).",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://recherche-entreprises.api.gouv.fr/search?q=751164757"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.fr-cm-kg.ai/events/XPAR/FR0013183985"
  },
  {
   "for": "the halt flag",
   "source": "https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.fr-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.gensight-biologics.com/investors/"
  },
  {
   "for": "the record",
   "source": "https://mcp.fr-cm-kg.ai/record/XPAR/FR0013183985"
  }
 ],
 "title": "GENSIGHT BIOLOGICS (FR0013183985) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}